On Wednesday, Oncothyreon Inc (USA) (NASDAQ:ONTY)’s shares declined -3.72% to $3.36.
Oncothyreon Inc (USA) (ONTY) declared that Robert Kirkman, M.D., President and Chief Executive Officer, is planned to present at the Jefferies 2015 Healthcare Conference on Wednesday, June 3, 2015 at 11:30 a.m. Eastern Time in New York.
Oncothyreon Inc., a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. Its clinical-stage product candidates comprise ONT-380, an orally active and selective small-molecule HER2 inhibitor, which is in two Phase 1b trials, one in combination with Kadcyla and another in combination with Xeloda and/or Herceptin; and ONT-10, a therapeutic vaccine in Phase 1 trial targeting the Mucin 1 peptide antigen (MUC1) for use in various cancer indications, counting breast, thyroid, colon, stomach, pancreas, ovarian, and prostate, in addition to certain types of lung cancer.
STERIS Corp (NYSE:STE)’s shares dropped -3.61% to $66.14.
STERIS Corp (STE) U.K. - April 30, 2015 - STERIS Corporation (STE) and Synergy Health plc (SYR.L) proclaimed that they have certified substantial compliance with the U.S. Federal Trade Commission (“FTC”) in response to its Request for Additional Information and Documentary Material (“Second Request”) relating to the proposed combination of STERIS and Synergy Health (“Combination”). Under the terms of the timing agreement, STERIS and Synergy Health have agreed not to close the Combination before June 2, 2015, unless the FTC first closes its investigation.
As a result, STERIS intends to replan the vote of its shareholders on the Combination by adjourning the meeting presently planned for May 12, 2015, to June 11, 2015. Synergy Health also intends to replan its shareholder meetings to the same date.
STERIS Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide.
At the end of Wednesday’s trade, E Commerce China Dangdang Inc (ADR) (NYSE:DANG)‘s shares dipped -3.39% to $10.25.
E Commerce China Dangdang Inc (ADR) (DANG) declared its unaudited financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Highlights
- Total net revenues for the first quarter of 2015 were RMB2,217.3 million ($357.7 million), a 27.7% enhance from the corresponding period in 2014. Gross Merchandise Value (“GMV”) from the marketplace in the first quarter of 2015 was RMB1,771.5 million ($285.8 million), a 49.4% enhance from the corresponding period in 2014. The combination of product revenue from principal business and GMV from the marketplace reached RMB3,920.2 million ($632.4 million) and grew 37.3% year-over-year.
- Dangdang had about 10.2 million active customers counting about 4.1 million new customers,in the first quarter of 2015, representing enhances of 18% and 46%, respectively, from the corresponding period in 2014. Total orders for the first quarter of 2015 were about 21.3 million, a 29% enhance from the corresponding period in 2014.
- Mobile orders accounted for 41% of total orders for the first quarter of 2015, contrast to 14% for the corresponding period in 2014.
- Net loss for the first quarter of 2015 was RMB60.2 million ($9.7 million), or negative 2.7% of total net revenues, contrast to net income of RMB2.0 million in the first quarter of 2014, or 0.1% of total net revenues.
E-Commerce China Dangdang Inc. operates as a business-to-consumer e-commerce company in the People’s Republic of China. It primarily sells books, periodicals, electronic publications, consumer electronics, and audio-visual products through its Website dangdang.com.
Crestwood Midstream Partners LP (NYSE:CMLP), ended its Wednesday’s trading session with -3.32% loss, and closed at $13.09.
Crestwood Midstream Partners LP (CMLP) stated its financial and operating results for the three months ended March 31, 2015.
In a separate press release issued recently, Crestwood Equity Partners LP (“Crestwood Equity”) and Crestwood Midstream declared the execution of a definitive agreement to merge the two partnerships and simplify Crestwood’s corporate structure into a single publicly-traded partnership with a merged enterprise value of about $7.5 billion. Under the terms of the agreement, each common unitholder of Crestwood Midstream will receive 2.75 common units of Crestwood Equity upon closing of the transaction. Completion of the transaction is subject to the approval of Crestwood Midstream’s unitholders and customary closing conditions. The transaction is predictable to close in the third quarter 2015.
Crestwood Midstream Partners LP provides gathering, processing, storage, and transportation solutions to customers in the crude oil, natural gas liquids (NGL), and natural gas sectors of the energy industry in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
